Drug recall D-0918-2023
Product
Bivalirudin for Injection 250 mg, 10 Single-Dose Vials, Rx Only, Manufactured for: Accord Healthcare, Inc. Durham, NC 27703 Manufactured by: Intas Pharmaceuticals Limited Ahmedabad-382 210, India, NDC 16729-275-67.
Reason for recall
Presence of Particulate Matter: Particulate matter identified as fiber.
Lots and codes
Lot #: M2212070 Exp. date 08/2024
Recall details
- Recalling firm
- Accord Healthcare, Inc., Durham, NC
- Quantity
- 1680 vials
- Distribution
- Nationwide within the United States
- Type
- Voluntary: Firm initiated
- Recall initiated
- July 3, 2023
- Terminated
- October 17, 2024
Related products
- Bivalirudin – drug information
- NDC 16729-275 Bivalirudin · Bivalirudin 250 mg/5mL · Accord Healthcare, Inc.